ALTER Relative Valuation - Theradiag SA

Watchlist Manager

Watchlist

Price: 1.26 EUR

Market Cap: €16.4m

Relative Value

There is not enough data to reliably calculate the relative value of ALTER.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

What is Relative Valuation?

How is Relative Value calculated?

ALTER Relative Value

Base Case

Worst Case

Base Case

Best Case

Valuation Multiples

View Details

Multiples Across Competitors

All Multiples

P/S

P/E

EV/EBITDA

EV/EBIT

Forward Multiples

		Market Cap	P/S	P/E	EV/EBITDA	EV/EBIT
FR	Theradiag SA PAR:ALTER	16.4m EUR	1.3	39.2	22.1	17.9
US	Abbott Laboratories NYSE:ABT	195.2B USD	4.4	29.9	16.9	23.1
US	Intuitive Surgical Inc NASDAQ:ISRG	170.7B USD	16.9	59.7	45.3	55.7
US	Stryker Corp NYSE:SYK	140.4B USD	5.6	43.3	21.9	26.5
IE	Medtronic PLC NYSE:MDT	129.8B USD	3.7	27.3	15.3	22.1
US	Boston Scientific Corp NYSE:BSX	109.9B USD	5.5	37.9	22.6	30.3
DE	Siemens Healthineers AG XETRA:SHL	45.5B EUR	2	21.5	11.9	16.8
US	IDEXX Laboratories Inc NASDAQ:IDXX	49.9B USD	11.5	46.9	33.5	37
US	Becton Dickinson and Co NYSE:BDX	51.2B USD	2.3	30.5	11.6	19.7
US	Edwards Lifesciences Corp NYSE:EW	44.5B USD	7.6	32.6	23.1	25.3
US	Resmed Inc NYSE:RMD	36B USD	6.7	24.3	17.1	19

			Revenue Growth	P/S to Growth
FR	Theradiag SA PAR:ALTER	Average P/S: 6.1 1.3	15%	0.1
US	Abbott Laboratories NYSE:ABT	4.4	8%	0.6
US	Intuitive Surgical Inc NASDAQ:ISRG	16.9	15%	1.1
US	Stryker Corp NYSE:SYK	5.6	9%	0.6
IE	Medtronic PLC NYSE:MDT	3.7	7%	0.5
US	Boston Scientific Corp NYSE:BSX	5.5	11%	0.5
DE	Siemens Healthineers AG XETRA:SHL	2	6%	0.3
US	IDEXX Laboratories Inc NASDAQ:IDXX	11.5	10%	1.2
US	Becton Dickinson and Co NYSE:BDX	2.3	3%	0.8
US	Edwards Lifesciences Corp NYSE:EW	7.6	11%	0.7
US	Resmed Inc NYSE:RMD	6.7	8%	0.8

			Earnings Growth	PEG
FR	Theradiag SA PAR:ALTER	Average P/E: 35.7 39.2	N/A	N/A
US	Abbott Laboratories NYSE:ABT	29.9	23%	1.3
US	Intuitive Surgical Inc NASDAQ:ISRG	59.7	19%	3.1
US	Stryker Corp NYSE:SYK	43.3	30%	1.4
IE	Medtronic PLC NYSE:MDT	27.3	22%	1.2
US	Boston Scientific Corp NYSE:BSX	37.9	32%	1.2
DE	Siemens Healthineers AG XETRA:SHL	21.5	17%	1.3
US	IDEXX Laboratories Inc NASDAQ:IDXX	46.9	13%	3.6
US	Becton Dickinson and Co NYSE:BDX	30.5	41%	0.7
US	Edwards Lifesciences Corp NYSE:EW	32.6	-23%	N/A
US	Resmed Inc NYSE:RMD	24.3	11%	2.2

			EBITDA Growth	EV/EBITDA to Growth
FR	Theradiag SA PAR:ALTER	Average EV/EBITDA: 21.9 22.1	N/A	N/A
US	Abbott Laboratories NYSE:ABT	16.9	9%	1.9
US	Intuitive Surgical Inc NASDAQ:ISRG	45.3	23%	2
US	Stryker Corp NYSE:SYK	21.9	12%	1.8
IE	Medtronic PLC NYSE:MDT	15.3	8%	1.9
US	Boston Scientific Corp NYSE:BSX	22.6	18%	1.3
DE	Siemens Healthineers AG XETRA:SHL	11.9	11%	1.1
US	IDEXX Laboratories Inc NASDAQ:IDXX	33.5	11%	3
US	Becton Dickinson and Co NYSE:BDX	11.6	8%	1.4
US	Edwards Lifesciences Corp NYSE:EW	23.1	13%	1.8
US	Resmed Inc NYSE:RMD	17.1	11%	1.6

			EBIT Growth	EV/EBIT to Growth
FR	Theradiag SA PAR:ALTER	Average EV/EBIT: 26.7 17.9	N/A	N/A
US	Abbott Laboratories NYSE:ABT	23.1	17%	1.4
US	Intuitive Surgical Inc NASDAQ:ISRG	55.7	25%	2.2
US	Stryker Corp NYSE:SYK	26.5	16%	1.7
IE	Medtronic PLC NYSE:MDT	22.1	17%	1.3
US	Boston Scientific Corp NYSE:BSX	30.3	27%	1.1
DE	Siemens Healthineers AG XETRA:SHL	16.8	15%	1.1
US	IDEXX Laboratories Inc NASDAQ:IDXX	37	11%	3.4
US	Becton Dickinson and Co NYSE:BDX	19.7	21%	0.9
US	Edwards Lifesciences Corp NYSE:EW	25.3	14%	1.8
US	Resmed Inc NYSE:RMD	19	12%	1.6

Theradiag SA
PAR:ALTER

Relative Value

Valuation Multiples

Multiples Across Competitors

ALTER Competitors Multiples
Theradiag SA Competitors

See Also

Company

Help

Tools

Stocks

Theradiag SA PAR:ALTER

Relative Value

Valuation Multiples

Multiples Across Competitors

ALTER Competitors Multiples Theradiag SA Competitors

See Also

Company

Help

Tools

Stocks

Theradiag SA
PAR:ALTER

ALTER Competitors Multiples
Theradiag SA Competitors